Binod Modi discusses Bajaj Finance s performance, including credit cost, growth potential, and asset quality concerns. Despite challenges like RBI restrictions and delinquencies, the company aims for growth through digital initiatives, facing competition and valuation risks.
Foram Parekh shares insights on CDMO companies positive outlook post-Covid correction, potential impact of Biosecure Law, concerns about Laurus s earnings improvement, Sun Pharma s specialty sales focus, and recommendations for pharma sector growth with Lupin and Dr Reddy s.
Sharekhan by BNP Paribas recommends ITC, a largecap company, for its growth plan, steady balance sheet, and favorable valuation. With a "buy" rating and price target of Rs 515, it offers over 20% upside potential.
One of the preferred picks for Sharekhan by BNP Paribas in this space is Mahindra Lifespace Developers as it believes that the company has a strong potential to scale up in the realty upcycle.
Gaurav Dua says: “As part of the multi-year up cycle in India, we have been saying for the past year, year and a half, the core investment themes are consumer, capital and the capex. That will include industrials, banks, financials and consumer companies. This should be part of your core holding that will also include property stocks, building material stocks.”